Alternate Access for TAVI: Stay Clear of the Chest
- PMID: 30443273
- PMCID: PMC6234489
- DOI: 10.15420/icr.2018.22.1
Alternate Access for TAVI: Stay Clear of the Chest
Abstract
Transcatheter aortic valve implantation (TAVI) is currently performed through an alternative access in 15% of patients. The transapical access is progressively being abandoned as a result of its invasiveness and poor outcomes. Existing data does not allow TAVI operators to favour one access over another - between transcarotid, trans-subclavian and transaortic - because all have specific strengths and weaknesses. The percutaneous trans-subclavian access might become the main surgery-free alternative access, although further research is needed regarding its safety. Moreover, the difficult learning curve might compromise its adoption. The transcaval access is at an experimental stage and requires the development of dedicated cavo-aortic crossing techniques and closure devices.
Keywords: Alternative access; TAVI; TAVR; alternative approach; trans-subclavian; transaortic; transapical; transcarotid; transcaval.
Conflict of interest statement
Disclosure: Thomas Modine is a consultant for Boston Scientific, Medtronic, Edwards Lifesciences, Cephea, MicroPort Scientific Corporation, GE Healthcare and Abbott; he received a research support grant from Edwards Lifesciences. Pavel Overtchouk has no conflict of interest to declare.
Figures
References
-
- Nishimura RA, Otto CM, Bonow RO et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70((2):):252–89. doi: 10.1016/j.jacc.2017.03.011. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
